entity

Therapeutic Resistance

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Therapeutic Resistance: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections
0Hypotheses
1Analyses
2Outgoing
7Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
Oxidative Stress-Based Cancer Therapyinhibitsmechanism0.80
Therapysuppressesprocess0.75

Incoming (7)

SourceRelationTypeStr
IL-6promotesprotein0.90
PI3K-AKT-mTOR Pathwaymediatespathway0.85
TNFcausesgene0.70
IL6causesgene0.70
intratumoral heterogeneityactivatesprocess0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why do systemic anti-inflammatory drugs fail in AD despite cardiovascular effica

clinical neurology | 2026-04-08 | 7 hypotheses Top: 0.455

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate noted clinical failures of TNF-α and IL-6 inhibitors in AD despite th

closed · Rounds: 4 · Score: 0.79 · 2026-04-09

Related Research

Hypotheses and analyses mentioning Therapeutic Resistance in their description or question text

No additional research found